ReviewDrugs & therapy perspectives : for rational drug selection and use2023
Nirmatrelvir plus ritonavir in COVID-19: a profile of its use.
Hannah A BlairPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papertrialcites it